Blood Eosinophil Reference Values and Determinants in a Representative Adult Population
Reshed Abohalaka,Selin Ercan,Lauri Lehtimaki,Saliha Selin Ozuygur Ermis,Daniil Lisik,Muwada Bashir Awad Bashir,Radhika Jadhav,Linda Ekerljung,Goran Wennergren,Jan Lotvall,Teet Pullerits,Helena Backman,Madeleine Radinger,Bright I. Nwaru,Hannu Kankaanranta
DOI: https://doi.org/10.1101/2024.10.10.24315149
2024-10-13
Abstract:Background The use of blood eosinophil count (BEC) as a prognostic biomarker in the management of conditions such as asthma and chronic obstructive pulmonary disease (COPD) may be complicated by factors like atopy, age, sex, smoking, and comorbidities. Therefore, we aimed to produce reference values for BEC, considering age, asthma, COPD, and clinical allergy for the general adult population.
Methods The West Sweden Asthma Study constitutes a population-representative clinical epidemiological cohort of randomly selected adults in western Sweden. From this cohort, n=1,145 took part in clinical examinations, including e.g. skin prick testing, specific immunoglobulin E, and BEC.
Results The upper limit (95th percentile) of BEC varied by age. It ranged between 400 to 500 cells/μL in the full sample, and from 300 to 400 cells/μL in subjects without asthma, COPD, and clinical allergy (n=710). Sex, smoking, atopy, clinical allergy, obesity, asthma, COPD, diabetes, and hypertension were statistically significantly associated with higher BEC levels. However, only asthma and clinical allergy in the full sample, and obesity and diabetes in those without asthma, COPD, or clinical allergy, remained statistically significant in multiple regression analyses.
Conclusion In a population-representative sample, the upper limit of BEC in healthy adults ranged between 300 and 400 cells/μL, varying by age. Age, smoking, obesity, asthma, COPD, and clinical allergy influence BEC levels and should be considered in clinical interpretation.
Allergy and Immunology